PSMA-617-01
NCT03511664
PSMA-617-01
Study of 177Lu-PSMA-617 in Metastatic Castrate-Resistant Prostate Cancer (VISION)
Status:
Closed to Accrual
III
Phase
2nd+
Line of Therapy
Advanced / Metastatic
Disease Stage
Biomarker(s)
N/A
Investigational
Product
177Lu-PSMA-617
Radioligand therapy (RLT) (i.v.)
Treatment Arms
o Experimental: 177Lu-PSMA-617 plus BS/BSC
o BS/BSC alone